Concepedia

Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo

Ali Roghanian, Ingrid Teige, Linda Mårtensson, Kerry L. Cox, Mathilda Kovacek, Anne Ljungars, Jenny Mattson, Annika Sundberg, Andrew Vaughan, Vallari Shah,

Cancer Cell · 2015 · 129 citations · 34 references

DOIFull text

Open access

Concepts

References

34

Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets

Raphael Clynes, Terri L. Towers, Leonard G. Presta et al. · Nature Medicine · 2000 · 2.7K citations

, , +5

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene

Guillaume Cartron, Laurent Dacheux, Gilles Salles et al. · Blood · 2002 · 1.9K citations · Full text

Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular Lymphoma

Wen‐Kai Weng, Ronald Levy · Journal of Clinical Oncology · 2003 · 1.3K citations

Rituximab Dose-Escalation Trial in Chronic Lymphocytic Leukemia

Susan O’Brien, Hagop M. Kantarjian, Deborah A. Thomas et al. · Journal of Clinical Oncology · 2001 · 588 citations

Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions.

Jeffrey V. Ravetch, B Perussia · The Journal of Experimental Medicine · 1989 · 571 citations · Full text

, , +19